Maxitrol Dosing
Administer Maxitrol (dexamethasone 0.1%/neomycin/polymyxin B) ophthalmic suspension 1–2 drops into each affected eye every 3–4 hours initially, with frequency adjusted based on severity; standard maintenance dosing is four times daily. 1, 2
Standard Dosing Regimen
- Initial dosing: Instill 1–2 drops into the affected eye(s) every 3–4 hours depending on severity of inflammation 2
- Maintenance dosing: Four times daily once acute inflammation is controlled 1, 3
- Treatment duration: Guided by clinical response, typically ranging from a few days for acute conjunctivitis to several weeks for chronic blepharitis 1
- Pediatric dosing: The same dosing schedule applies to children aged 2 years and older as in adults 1
- For pediatric bacterial conjunctivitis specifically, a four-times-daily regimen for 5–7 days is typical 1
Critical Prescribing Limits
- Initial prescription should not exceed 20 mL, and renewal requires physician re-examination with magnification (slit lamp biomicroscopy) and fluorescein staining when appropriate 4
- Re-evaluate after 2 days if signs and symptoms fail to improve 4
- Children can resume school after 24 hours of treatment initiation when symptoms begin improving 1
Absolute Contraindications
Never use Maxitrol in the following situations:
- Bacterial keratitis or corneal ulceration as monotherapy – requires immediate ophthalmology referral and fortified antibiotics instead 1, 4
- Viral ocular diseases including epithelial herpes simplex keratitis, vaccinia, and varicella 1
- Mycobacterial or fungal eye infections 1
- Active epithelial defects – preservatives in the formulation worsen epithelial damage 1, 3
- Contact lens wearers with bacterial conjunctivitis – higher complication risk requiring specialist referral 1
Duration-Based Safety Considerations
- If therapy extends beyond 8 weeks, switch to loteprednol etabonate 0.5%/tobramycin 0.3% (Zylet), which carries lower risk of intraocular pressure elevation and cataract progression 1, 3
- Monitor intraocular pressure (IOP) if treatment continues for 10 days or longer 4
- Dexamethasone carries significant risk of steroid-induced glaucoma with prolonged use 1
Monitoring Requirements
- Baseline and periodic IOP measurement is essential during corticosteroid therapy 5
- Pupillary dilation should be performed periodically to evaluate for cataract formation 5
- Fungal cultures should be obtained if persistent corneal ulceration develops, as fungal infections are prone to develop with long-term corticosteroid use 4
Antibiotic Resistance Prevention
- Rotate antibiotic formulations intermittently using agents with different mechanisms of action to reduce emergence of resistant organisms 1, 3
- Avoid chronic prophylactic use without clear indication, as this promotes resistant organisms including methicillin-resistant Staphylococcus aureus 1, 3
- Prolonged topical antibacterial use may lead to overgrowth of nonsusceptible organisms including fungi 4
Immediate Referral Criteria
Refer to ophthalmology immediately for:
- Severe or moderate-to-severe pain 1
- Lack of clinical response after 3–4 days of therapy 1
- Severe purulent discharge 1
- Contact lens wearers with bacterial conjunctivitis 1
- Any suspicion of bacterial keratitis or corneal ulceration 5, 1
Common Pitfalls to Avoid
- Never combine Maxitrol with eye patching, especially in contact lens wearers, due to increased bacterial keratitis risk 1, 3
- Do not continue treatment beyond 2 weeks without reassessment and consideration of alternative diagnoses or resistant pathogens 1
- Do not use preserved formulations when epithelial defects are present 1, 3
- Vision may be temporarily blurred following administration; patients should exercise caution when operating machinery or driving 4